How to improve therapy for adult acute myeloid leukemia: studies of the AML Cooperative Group in the Federal Republic of Germany

J Cancer Res Clin Oncol. 1990;116(1):97-9. doi: 10.1007/BF01612647.
No abstract available

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols*
  • Colony-Stimulating Factors / therapeutic use
  • Cytarabine / therapeutic use
  • Daunorubicin / therapeutic use
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Growth Substances / therapeutic use
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / mortality
  • Middle Aged
  • Survival Rate
  • Thioguanine / therapeutic use

Substances

  • Colony-Stimulating Factors
  • Growth Substances
  • Cytarabine
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Thioguanine
  • Daunorubicin

Supplementary concepts

  • DAT protocol 1